Saturday, October 31, 2026

EUR/CHF Over 1% Up In The Last 21 Sessions

ViaNews Editorial Team

February 1, 2023

EUR/CHF Over 1% Up In The Last 21 Sessions

(VIANEWS) - EUR/CHF (EURCHF) has been up by 1.59% for the last 21 sessions. At 14:07 EST on Wednesday, 1 February, EUR/CHF (EURCHF) is $1.00.

EUR/CHF's yearly highs and lows, it's 6.109% up from its 52-week low and 5.711% down from its 52-week high.

Volatility

EUR/CHF's last week, last month's, and last quarter's current intraday variation average was a negative 0.45%, a positive 0.02%, and a positive 0.29%, respectively.

EUR/CHF's highest amplitude of average volatility was 0.45% (last week), 0.34% (last month), and 0.29% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, EUR/CHF's Forex is considered to be overbought (>=80).

News about

  • Eur/usd remains bid and close to 1.0900. According to FXStreet on Monday, 30 January, "The optimism around the single currency remains well and sound in the European afternoon, with EUR/USD posting decent gains near the 1.0900 hurdle.", "The sharp yearly rally in EUR/USD appears to have met an initial and decent barrier around the 1.0930 for the time being."
  • Eur/usd reflects market tension around 1.0870 ahead of German gdp, fed vs. ECB battle. According to FXStreet on Monday, 30 January, "Additionally underpinning the EUR/USD upside are the mixed US data and the cautious optimism in the market as China returns to trading after one full week of the Lunar New Year holidays.", "While portraying the mood, the US Treasury bond yields grind higher but the stock futures print mild losses and challenge the EUR/USD traders. "
  • Eur/usd probes three-day downtrend near mid-1.0800s, eurozone gdp, US consumer confidence eyed. According to FXStreet on Tuesday, 31 January, "Despite the latest corrective bounce, a clear upside break of the support-turned-resistance line from January 10, close to 1.0860 at the latest, becomes necessary to recall EUR/USD buyers."
  • Eur/usd price analysis: bears approach 1.0800 during four-day downtrend. According to FXStreet on Tuesday, 31 January, "Also keeping the EUR/USD bears hopeful are the bearish MACD signals and the clear downside break of the three-week-old support line, not to forget sustained trading below the 200-Hour Moving Average (HMA).", "Following that, multiple resistances near 1.0900 could challenge the EUR/USD rebound before highlighting the monthly top near 1.0930."

More news about EUR/CHF (EURCHF).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com